Symposium: Precision Oncology: The Promise for Translating Personal Genomics into Clinical

Symposium: Precision Oncology: The Promise for Translating Personal Genomics into Clinical

Friday, April 30, 2021 • 10:00 AM - 12:00 PM (EST)

 

Kevin Gardner, MD, PhDChair
Kevin Gardner, MD, PhD
Columbia University Medical Center

Elizabeth Whitley, DVM, PhDCo-Chair
Elizabeth Whitley, DVM, PhD
MD Anderson Cancer Center

Session Description: Tapping into the vast amount of information stored in the genome holds great promise for the development of targeted, patient-specific clinical decision-making. In this symposium, we highlight several vanguard studies that support developing knowledge-based therapeutics and preventions for cancer. The first presentation of this symposium will focus on the use of genomic technologies and bioinformatics analysis to determine relationships between germ-line and somatic alterations in populations and cancer risk and progression. The second presentation will delve into hereditary differences in Vitamin D metabolism and prostate cancer aggressiveness and mortality. The third presentation will describe genetic and environmental factors among Latina women that affect the risk of developing breast cancer or of having progressive disease.

  • Chair - Welcome and Introductions
  • 10:00 AM - 10:40 AM
    Population and Tumor Heterogeneity in Cancer Genomics and Precision Oncology
    John Carpten, PhD • Keck School of Medicine of the University of Southern California
  • 10:40 AM - 11:20 AM
    The Role of Vitamin D Signaling in Prostate Cancer Disparities
    Richard Kittles, PhD • City of Hope
  • 11:20 AM - 12:00 PM
    Tumor Genomics in Latina Breast Cancer
    Susan Neuhausen, PhD • City of Hope
  • Questions and Answers